节点文献

全新药物设计方法与常用软件及其在抗癌药物设计中的应用

Applications of the common software and methods of de novo drug design in the antitumor drug design

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 殷丽陈临溪

【Author】 YIN Li;CHEN Linxi;Institute of Pharmacy and Pharmacology,University of South China;

【机构】 南华大学药物药理研究所

【摘要】 计算机辅助药物设计已普遍应用于药物研发过程,大大加快了药物开发的速度。特别是全新药物设计方法可以用于识别作用于特异性靶点的全新配体结构。全新药物设计常用软件有LUDI,LigBuilder,LeapFrog,SPROUT和SYNOPSIS等,常用方法有片段连接、片段生长、侧链替换和骨架跃迁等。全新药物设计方法在一些抗癌化合物,如纺锤体驱动蛋白抑制剂、血管内皮生长因子抑制剂、亲环蛋白A抑制剂和BRAF抑制剂等的发现方面,已经发挥了重要作用。综述全新药物设计方法与常用软件,并举例讨论其在新型抗癌药物领域中的应用。

【Abstract】 Computer aided drug design had become part of the drug discovery process,greatly improved the speed of drug development compared with traditional drug finding methods.In particular,the de novo drug design method could be used to identify ligands with novel structure for a special target.Through computer simulation,researchers could find new ideas about how to change a compound to improve the drug properties or how to assemble some fragments to generate candidates which be drug-like,synthetically accessible and high affinity for a target.The common software of de novo design included LUDI,MCSS,LigBuilder,SPROUT,SYNOPSIS,BREED,LeapFrog and RACHEL,etc.The methods were fragments link and grow,side chain replacement,parent molecule evolve,template,scaffold hopping and so on.Discovery and development of cancer drugs had been revolutionized over the last decade.De novo drug design methods had already played a significant role in the discovery of some anticancer compounds such as kinesin spindle protein inhibitors,vascular endothelial growth factor inhibitors,cyclophilin A inhibitors,cell division cycle protein CDC25 inhibitors and BRAF inhibitors.The common software and methods of de novo drug design were summarized in this review and their applications in antitumor drug design were discussed.

【关键词】 全新药物设计抗癌药LUDILigBuilderLeapFrog
【Key words】 de novo drug designantitumor drugLUDILigBuilderLeapFrog
【基金】 国家自然科学基金(81270420);教育部留学归国人员科研启动基金(20091590);湖南省高校创新平台开放基金(10K051);湖南省自然科学基金省市联合(衡阳)基金重点项目(12JJ8013);湖南省十二五重点学科资助
  • 【文献出处】 药学实践杂志 ,Journal of Pharmaceutical Practice , 编辑部邮箱 ,2014年01期
  • 【分类号】R918
  • 【被引频次】3
  • 【下载频次】747
节点文献中: 

本文链接的文献网络图示:

本文的引文网络